Health
A new study of hundreds of twins suggests that teens with poor executive function are more likely to take risks, including experimenting with drugs and alcohol, but are not more prone to addiction.
The odds of filling out a perfect NCAA men’s basketball tournament are beyond impossible, according to applied mathematics professor Mark Ablowitz.
Research suggests lactate, a metabolic byproduct that can interfere with sports performance, plays a role in cancer formation. And while people who regularly exercise tend to be able to clear lactate, others with a sedentary lifestyle, combined with excess sugar intake, may have a harder time.
Using mathematical calculations, a new study bears the recipe for how marathoners could break the world record among males, shaving about four and a half minutes off the fastest time.
CU Boulder and JILA researcher Tom Perkins has spent the last seven years trying to understand how and why proteins fold and unfold.
A CU Boulder research team has found marked health benefits from electric-assist commuter bikes and "passive-cycling." Now the team is studying an under-the-desk cycle that shows similar promise.
Preliminary evidence shows changes in gut microbiota could contribute to poor artery health with aging. This condition is worsened by eating a "Western diet" high in fat and sugars and low in fiber. With a $3 million grant, CU Boulder researchers are investigating further.
CU Boulder scientists have found that 4- and 5-year-olds who go to bed later and are exposed to brighter nighttime light experience delays in their biological clock, which could lead to night-owl schedules and associated health problems.
A new study with implications for human health found that prebiotics – dietary fibers found in foods like chicory, artichokes, raw garlic and onions – improved sleep and buffered stress.
Non-steroidal anti-inflammatory drugs (NSAIDS) like aspirin and ibuprofen have been found to inhibit enzymes that play a key role in causing sepsis, according to a new study by BioFrontiers researcher Hubert YIn. He's now exploring ways to repurpose the drugs to treat the deadly condition which impacts more than 1 million people annually.